Literature DB >> 3665909

Susceptibility of Clostridium difficile to metronidazole, its bioactive metabolites and tinidazole.

R Bannatyne, J Jackowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3665909     DOI： 10.1007/bf02013130

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis.

Authors:  J Dzink; J G Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

2.  Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria.

Authors:  J P O'Keefe; K A Troc; K D Thompson
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics.

Authors:  A W Chow; N Cheng; K H Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

Authors:  D G Teasley; D N Gerding; M M Olson; L R Peterson; R L Gebhard; M J Schwartz; J T Lee
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321
  4 in total
  1 in total

1.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.